Structure (Dobutamine Injection Usp 1)
Dobutamine Injection, Solution
Product Images NDC 0143-9141
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dobutamine (NDC 0143-9141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label (Dobutamine Injection Usp 2)
This is a description of a medication called Dobutamine Injection USP used for intravenous administration. The solution is available in a 250 mg per 20 mL bottle. The text includes the name of the drug and dosage information, but does not detail what the medication is used for or any potential side effects or precautions.*
Carton (Dobutamine Injection Usp 3)
This is a description of the drug DOBUTamine, which comes in a 250 mg per 20 mL injection for intravenous use only. It must be diluted before use and used within 24 hours of dilution. Each mL contains Dobutamine hydrochloride equivalent to 25 mg of Dobutamine, and other ingredients. The package insert should be consulted for dosage and administration instructions. The drug does not contain any antimicrobial preservatives and should be stored at 20-25°C. The drug is manufactured by Hiha Farmigeutica in Portugal. There is also a mention of NDC and Rxonly codes, and a lot number (PLB24G-WES).*
Serialization Image (Dobutamine Injection Usp 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
